Treatment of Adult Acute Lymphoblastic Leukemia (ALL) With a Focus on …Cancer Network[17] The prognostic role of CD20 expression in ALL is controversial; nonetheless, targeted therapies directed against this marker have been developed. Recent data fr…
Proactive Investors USA & CanadaCTI launches Pixuvri in EU to treat adult patients with refractory aggressive …pharmabiz.comThe European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use has accepted PIX306, CTI's ongoin…
Proactive Investors USA & CanadaCell Therapeutics Announces European Launch Of Pixuvri® For Treatment Of …Sacramento BeeThe European Medicines Agency's (the "EMA") Committee for Medicinal Products for Human Use has accepted PIX306, CTI…
Proactive Investors USA & CanadaCell Therapeutics shares surge on commercial launch of lymphoma drug in …Proactive Investors USA & CanadaThe company said it is also currently accruing patients into a phase 3 trial comparing pixantrone and rituximab w…
Cell Therapeutics Announces European Launch of Pixuvri(R) for Treatment of …PR Newswire UK (press release)The European Medicines Agency's (the "EMA") Committee for Medicinal Products for Human Use has accepted PIX306, CTI's ongoing …
-First and only approved therapy for this patient population PR NewswireEquities.comThe European Medicines Agency's (the "EMA") Committee for Medicinal Products for Human Use has accepted PIX306, CTI's ongoing randomized controlled ph…
Proactive Investors USA & CanadaCell Therapeutics Announces European Launch Of Pixuvri® For Treatment Of …The Herald | HeraldOnline.comThe European Medicines Agency's (the "EMA") Committee for Medicinal Products for Human Use has accep…
'No malignancy risk' with biologic response modifiersNews-Medical.net… Cancer Center in Houston, Texas, USA, and colleagues identified 63 studies reporting safety data for a total of 29,423 RA patients treated with abatacept, adalimumab, anak…
Doctor suspended, fined for inappropriate treatmentTODAYonlineDr Teoh had recommended and administered a therapy – Rituximab, Velcade, Dexamethasone, Thalidomide, Zometa therapy, also known as the VELCADE-based Therapy – that he should have known, or k…
Pharmacyclics Management Discusses Q4 2012 Results – Earnings Call TranscriptSeeking AlphaThis is Phase III study of ibrutinib in combination with bendamustine/rituximab in patients with relapsed or refractory CLL or SLL. This is a randomized, multicen…